143 related articles for article (PubMed ID: 17395176)
1. Antinociceptive efficacy of lacosamide in rat models for tumor- and chemotherapy-induced cancer pain.
Beyreuther BK; Callizot N; Brot MD; Feldman R; Bain SC; Stöhr T
Eur J Pharmacol; 2007 Jun; 565(1-3):98-104. PubMed ID: 17395176
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy.
Beyreuther B; Callizot N; Stöhr T
Eur J Pharmacol; 2006 Jun; 539(1-2):64-70. PubMed ID: 16682022
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive effect of Butea monosperma on vincristine-induced neuropathic pain model in rats.
Thiagarajan VR; Shanmugam P; Krishnan UM; Muthuraman A; Singh N
Toxicol Ind Health; 2013 Feb; 29(1):3-13. PubMed ID: 22287618
[TBL] [Abstract][Full Text] [Related]
4. Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF.
Beyreuther BK; Geis C; Stöhr T; Sommer C
Neuropharmacology; 2007 Apr; 52(5):1312-7. PubMed ID: 17360008
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterisation of the rat brachial plexus avulsion model of neuropathic pain.
Rodrigues-Filho R; Campos MM; Ferreira J; Santos AR; Bertelli JA; Calixto JB
Brain Res; 2004 Aug; 1018(2):159-70. PubMed ID: 15276874
[TBL] [Abstract][Full Text] [Related]
6. Lacosamide displays potent antinociceptive effects in animal models for inflammatory pain.
Stöhr T; Krause E; Selve N
Eur J Pain; 2006 Apr; 10(3):241-9. PubMed ID: 15946870
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive and anti-allodynic effects of oral PL37, a complete inhibitor of enkephalin-catabolizing enzymes, in a rat model of peripheral neuropathic pain induced by vincristine.
Thibault K; Elisabeth B; Sophie D; Claude FZ; Bernard R; Bernard C
Eur J Pharmacol; 2008 Dec; 600(1-3):71-7. PubMed ID: 18938155
[TBL] [Abstract][Full Text] [Related]
8. Face-to-face comparison of the predictive validity of two models of neuropathic pain in the rat: analgesic activity of pregabalin, tramadol and duloxetine.
Le Cudennec C; Castagné V
Eur J Pharmacol; 2014 Jul; 735():17-25. PubMed ID: 24726848
[TBL] [Abstract][Full Text] [Related]
9. The antinociceptive effect of acetaminophen in a rat model of neuropathic pain.
Im KS; Jung HJ; Kim JB; Lee JM; Park HJ; Joo CH; Moon DE
Kaohsiung J Med Sci; 2012 May; 28(5):251-8. PubMed ID: 22531303
[TBL] [Abstract][Full Text] [Related]
10. Lacosamide has protective disease modifying properties in experimental vincristine neuropathy.
Geis C; Beyreuther BK; Stöhr T; Sommer C
Neuropharmacology; 2011 Sep; 61(4):600-7. PubMed ID: 21586299
[TBL] [Abstract][Full Text] [Related]
11. Analgesic ineffectiveness of lacosamide after spinal nerve ligation and its sodium channel activity in injured neurons.
Hagenacker T; Schäfer N; Büsselberg D; Schäfers M
Eur J Pain; 2013 Jul; 17(6):881-92. PubMed ID: 23229998
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of gabapentin and S-(+)-3-isobutylgaba in a rat model of postoperative pain.
Field MJ; Holloman EF; McCleary S; Hughes J; Singh L
J Pharmacol Exp Ther; 1997 Sep; 282(3):1242-6. PubMed ID: 9316831
[TBL] [Abstract][Full Text] [Related]
13. The combined predictive capacity of rat models of algogen-induced and neuropathic hypersensitivity to clinically used analgesics varies with nociceptive endpoint and consideration of locomotor function.
Munro G; Storm A; Hansen MK; Dyhr H; Marcher L; Erichsen HK; Sheykhzade M
Pharmacol Biochem Behav; 2012 May; 101(3):465-78. PubMed ID: 22366217
[TBL] [Abstract][Full Text] [Related]
14. Anti-nociceptive synergism of morphine and gabapentin in neuropathic pain induced by chronic constriction injury.
De la O-Arciniega M; Díaz-Reval MI; Cortés-Arroyo AR; Domínguez-Ramírez AM; López-Muñoz FJ
Pharmacol Biochem Behav; 2009 May; 92(3):457-64. PubMed ID: 19463259
[TBL] [Abstract][Full Text] [Related]
15. Analgesic effect of gabapentin in a rat model for chronic constrictive injury.
Ma LL; Liu W; Huang YG; Yang N; Zuo PP
Chin Med J (Engl); 2011 Dec; 124(24):4304-9. PubMed ID: 22340405
[TBL] [Abstract][Full Text] [Related]
16. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy.
Flatters SJ; Bennett GJ
Pain; 2004 May; 109(1-2):150-61. PubMed ID: 15082137
[TBL] [Abstract][Full Text] [Related]
17. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat.
Honore P; Donnelly-Roberts D; Namovic MT; Hsieh G; Zhu CZ; Mikusa JP; Hernandez G; Zhong C; Gauvin DM; Chandran P; Harris R; Medrano AP; Carroll W; Marsh K; Sullivan JP; Faltynek CR; Jarvis MF
J Pharmacol Exp Ther; 2006 Dec; 319(3):1376-85. PubMed ID: 16982702
[TBL] [Abstract][Full Text] [Related]
18. Gabapentin and its salicylaldehyde derivative alleviate allodynia and hypoalgesia in a cisplatin-induced neuropathic pain model.
Ahmad N; Subhan F; Islam NU; Shahid M; Rahman FU; Sewell RDE
Eur J Pharmacol; 2017 Nov; 814():302-312. PubMed ID: 28865678
[TBL] [Abstract][Full Text] [Related]
19. Ethosuximide reduces allodynia and hyperalgesia and potentiates morphine effects in the chronic constriction injury model of neuropathic pain.
Hamidi GA; Ramezani MH; Arani MN; Talaei SA; Mesdaghinia A; Banafshe HR
Eur J Pharmacol; 2012 Jan; 674(2-3):260-4. PubMed ID: 22134003
[TBL] [Abstract][Full Text] [Related]
20. Experience with gabapentin for neuropathic pain in adolescents: report of five cases.
Butkovic D; Toljan S; Mihovilovic-Novak B
Paediatr Anaesth; 2006 Mar; 16(3):325-9. PubMed ID: 16490100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
